Vascular wound closing apparatus and method

Abstract

Wound closure apparatus is provided including a body having an elongated, lowermost force-transmitting surface operable to be placed in a proximal, external, wound-closing position on a patient, together with a force-exerting assembly coupled with the body and operable to exert a downwardly directed force serving to generate wound-closing pressure against the patient's tissue. The force-transmitting surface is preferably three-dimensionally asymmetric so that forces of different magnitude are exerted at different locations along the length of the surface. The apparatus is especially designed for the closure of wounds attendant to endovascular interventions, e.g., a femoral artery puncture wound incident to percutaneous cardiac intervention (PCI), and is capable of quickly effecting wound closure with a time-to-ambulation (TTA) of approximately 60 minutes, and with a very low complication rate.

Description

CROSS-REFERENCE TO RELATED APPLICATION[0001]This application is a continuation of identically-titled application Ser. No. 13 / 105,255 filed May 11, 2011, and also claims the benefit of Provisional Application Ser. No. 61 / 461,923, filed Jan. 25, 2011, and Provisional Application Ser. No. 61,463,373, filed Feb. 16, 2011, all of which are incorporated by reference herein in their entirety.BACKGROUND OF THE INVENTION[0002]1. Field of the Invention[0003]The present invention is broadly concerned with improved apparatus and methods for closure of wounds in the tissue of patients, and especially wounds attendant to endovascular interventions, such as percutaneous cardiac intervention (PCI,) wherein closure is defined as the time from removal of the catheter to ambulating the patient. More particularly, the invention is concerned with such apparatus and methods which employs a rigid wound-closing body adapted to be placed adjacent and along the length of the wound, together with a force-exer...

AI Technical Summary

Benefits of technology

[0024]different sheath sizes, blood chemistries (e.g., INR >1.5, or the presence of blood thinners), and degrees of intervention can be accommodated by increasing the closure time;

[0030]Advantageously, the force-exerting assembly is designed to exert a substantially constant and time-invariant force through the force-transmitting surface; this, coupled with the preferred asymmetric force application serves to reduce the patient's blood pressure and flow within the artery and especially at the arteriotomy.

Problems solved by technology

Poorly executed wound closures may give rise to complications which are costly, increase hospital stays and affect morbidity.

For example, inadequate hemostasis can lead to significant blood loss, patient discomfort, vessel occlusion, thrombosis, formation of arteriovenous fistula, and pseudoaneurysm requiring surgical intervention and / or steps to avoid infections.

However, in actual practice, there are a number of significant problems.

For example, manual pressure that is too firm does not allow sufficient clotting factors to accumulate at the arteriotomy.

Even more important, the person exerting manual pressure can tire during the 30-minute holding time, or the fingers may move or may not be placed properly.

The person may also temporarily stop the application of pressure to examine the wound, causing a disruption of the maturing clot.

Finally, different body types present different manual pressure issues, e.g., if the panniculus intrudes on the person's left hand, pressure variations may be induced as the patient breathes and the panniculus moves.

These combined techniques have many of the same problems as straightforward manual pressure closures, and the external devices may be difficult to deploy on obese patients.

Thus, while manual procedures are of long standing, they are deficient in that they can be tiring, require careful training, and represent inefficient use of the time of valuable medical personnel.

Drawbacks of these procedures include a maximum French size of 8 Fr and the fact that the anchor and collagen plug must be left in the body for up to 90 days.

Suture-mediated intra-arterial anchor techniques have also been used, but these are deficient in that the sutures remain in the body until absorbed, and nonetheless require that the anchor and plug be left in the body for an extended period.

In response to these problems, various specialized vascular closure devices (VCDs) have been proposed, such as the device disclosed in U.S. Pat. No. 5,307,811 and commercialized under the designation “FemoStop.” While these and other VCDs have achieved widespread use, no prior VCD has fully solved the problems inherent in wound closures.

A further complication is that the heart is beating, making the pressure (sum of internal and external pressure) variable.

If there were no flow restriction, the arteriotomy would leak, resulting in a hematoma.

Images